BioHealth News Archive
Qiagen (QGEN) Completes Exiqon Tender Offer
QIAGEN N.V. (Nasdaq: QGEN) announced the successful completion of the conditional, voluntary public tender offer for the shares in Exiqon A/S, a world leader…
Read More16 providers and vendors join IBM Watson Health in medical imaging collaborative – MedCity News
Another week, another new initiative for IBM Watson Health. Wednesday, IBM announced the formation of a Watson Health medical imaging collaborative, seeking to make…
Read MoreScience Center Releases 2016 Annual Review and Economic Impact Study
Between June 2015 and June 2016, we’ve created more spaces and places for people to engage with the Science Center; honed and expanded our…
Read MoreSoPE Piranha Pond Pitch Event! Tickets, Wed, Jun 29, 2016 at 6:00 PM – Eventbrite
Join us for a thrilling evening of start-up pitches from multiple sectors in healthcare including: Services, Health IT, Biotechnology, Medical Devices and Diagnostics. Applications…
Read MoreUniversity System of Maryland hopes $25M venture fund will help create more commercial businesses – Baltimore Business Journal
The University System of Maryland is hoping a new $25 million venture capital fund it established will help spin off more commercial businesses —…
Read MoreQiagen, CosmosID Join International Urban Microbiome Project – GenomeWeb
Qiagen and CosmosID have joined the Metagenomics and Metadesign of Subways and Urban Biomes (MetaSUB) consortium, an international five-year effort led by Weill Cornell…
Read MoreMoney Behind First CRISPR Test? It’s from Internet Billionaire Sean Parker
The first proposed test of CRISPR gene-editing technology in human beings is being funded by Internet billionaire Sean Parker, MIT Technology Review has learned.…
Read MoreInnovation Village forges partnership with socially conscious incubator – Baltimore Business Journal
Innovation Village, an effort to spur economic development in West Baltimore, is partnering with Howard County's Conscious Venture Lab to help develop fledgling companies…
Read MoreBiotech startups face bigger funding challenges than other industries
When David R. Tabatadze’s small biotechnology venture ran out of money in 2013, he almost gave up on it. He went to pharmaceutical companies…
Read MoreFDA Accepts Emergent BioSolutions’ Supplemental Biologics License Application for Large-Scale Manufacturing of BioThrax in Building 55
Emergent BioSolutions Inc. (NYSE:EBS) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review Emergent’s supplemental Biologics License Application (sBLA)…
Read MorePredicting Contagiousness to Limit the Spread of Disease
Imagine the workplace during flu season. Some people get sick and display clear symptoms—a warning sign to coworkers to avoid contact and for that…
Read MoreBiotech is booming – Cambridge News
The UK biotechnology sector continues to build on the success of previous years, raising an unprecedented £900m on the London Stock Exchange in 2015…
Read MoreDo cities need a point-person to lead innovation?
As cities continue to invest more in smart city technologies, questions surrounding how to staff those moves can puzzle city leaders. Martin O’Malley, the…
Read MoreEmergent BioSolutions: Underlying Value To Be Realized Following Aptevo Spin-Off – Seeking Alpha
Emergent BioSolutions Inc. is a global specialty pharmaceutical company, which offers specialized products to governments and healthcare providers. The company derives most of its…
Read MorePersonal Genome Diagnostics Co-Founders Named EY Entrepreneur Of The Year 2016® Maryland
Personal Genome Diagnostics Inc. (PGDx), a provider of advanced cancer genome testing products and services, today announced that co-founders Luis Diaz, MD, and Victor…
Read More